Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.

El Mashed, Shereen; O'Donovan, Tracey R; Kay, Elaine; O'Grady, Anthony; McManus, Damian; Turkington, Richard C; McKenna, Sharon L

El Mashed, Shereen; O'Donovan, Tracey R; Kay, Elaine; O'Grady, Anthony; McManus, Damian; Turkington, Richard C; McKenna, Sharon L.

Afiliación

El Mashed S; Department of Histopathology, National Liver Institute in Egypt, Menoufia University, Shibin el Kom, Egypt.
O'Donovan TR; Cancer Research UCC, Western Gateway Building, University College Cork, Cork, Ireland.
Kay E; Cancer Research UCC, Western Gateway Building, University College Cork, Cork, Ireland.
O'Grady A; Department of Histopathology, Beaumont Hospital/Royal College of Surgeons in Ireland, Dublin, Ireland.
McManus D; Department of Histopathology, Blackrock Clinic, Dublin, Ireland.
Turkington RC; Department of Histopathology, Beaumont Hospital/Royal College of Surgeons in Ireland, Dublin, Ireland.
McKenna SL; Department of Pathology, Belfast City Hospital, Belfast, UK.

BMC Cancer ; 22(1): 908, 2022 Aug 20.

Article en En | MEDLINE | ID: mdl-35986318

Asunto(s)

Adenocarcinoma; Neoplasias Esofágicas; Adenocarcinoma/patología; Apoptosis; Autofagia; Biomarcadores de Tumor/metabolismo; Caspasa 3; Humanos; Terapia Neoadyuvante; Pronóstico; Estudios Retrospectivos

Palabras clave

Caspase-3; LC3B; autophagy; oesophageal adenocarcinoma; predictive biomarkers

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Egipto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google